期刊
BIOMEDICINES
卷 11, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines11102792
关键词
pancreatic ductal adenocarcinoma; apoptosis; ferroptosis; necroptosis; pyroptosis
Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor with poor prognosis and resistance to treatment. Recent studies have shown that ferroptosis, necroptosis, and pyroptosis, as non-apoptotic cell death processes, play a crucial role in the prognosis and treatment of PDAC.
Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor characterized by poor prognosis and resistance to treatment. Resistance to apoptosis, a cell death process, and anti-apoptotic mechanisms, are some of the hallmarks of cancer. Exploring non-apoptotic cell death mechanisms provides an opportunity to overcome apoptosis resistance in PDAC. Several recent studies evaluated ferroptosis, necroptosis, and pyroptosis as the non-apoptotic cell death processes in PDAC that play a crucial role in the prognosis and treatment of this disease. Ferroptosis, necroptosis, and pyroptosis play a crucial role in PDAC development via several signaling pathways, gene expression, and immunity regulation. This review summarizes the current understanding of how ferroptosis, necroptosis, and pyroptosis interact with signaling pathways, the genome, the immune system, the metabolism, and other factors in the prognosis and treatment of PDAC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据